Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mondae vs Potere Health MD

Mondae
Site position #70

Higher grade

vs+1.8
Potere Health MD
Site position #88

Lower grade

The verdict

Mondae takes it — 74.3/100 to 72.5/100, but only just.

Mondae grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mondae sells both molecules at some of the lowest figures in this ranking, bills every 28 days, and names a pharmacy on every product page except the two that matter. Potere Health MD is close behind and may still be the better fit — see the factor split below.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMondae +5
90
85
Dose & formulationEven
64
64
Clinical oversightPotere Health MD +15
72
87
Labs & monitoringPotere Health MD +2
52
54
FulfillmentMondae +22
89
67
Contract termsMondae +16
77
61
Mondae · left barPotere Health MD · right bar

The numbers

MetricMondaePotere Health MD
WeighScore74.3/10072.5/100
GradeCC
Site position#70#88
Semaglutide$87 per 28 days (thirteen charges a year; $75/mo requires a three-month prepay)$80/mo (starting dose, compounded)
Tirzepatide$126 per 28 days (thirteen charges a year; $124/mo requires a three-month prepay)$135/mo (starting dose, compounded)
CoverageAll 50 states1 state
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Mondae

Site position #70 · C

Strengths

  • $87 and $126 per cycle are at the low end of what this ranking records for either molecule
  • No membership or consultation fee is charged, stated on the checkout itself rather than in marketing copy
  • Free shipping, and support hours are published as 8:00 AM to 8:00 PM Eastern
  • A priced injectable peptide menu sits beside the GLP-1 lines

Where it loses points

  • A Mondae month is 28 days — the intake says shipped and billed every 28 days, which is thirteen charges a year
  • The homepage figures “from $75” and “from $124” are three-month prepay rates; the month-to-month rates are $87 and $126
  • The hero reads “prices start from $87” above a grid whose lowest figure is $63
  • The peptide rows are labeled billed monthly under three-month rates
  • A pharmacy, Greenwich, is named on the sermorelin, NAD+ and glutathione pages and on neither GLP-1 page — the compounder for the drug this row is about is not disclosed
  • No clinician, medical group or NPI is named; the Terms name a telehealth platform only
  • Shipping is quoted at about two days in the plan FAQ and five to seven business days in the shipping policy
Potere Health MD

Site position #88 · C

Strengths

  • Low starting pricing (about $80-$135/month) with no subscription lock-in
  • Physician-led by a named MD, not automated messaging
  • Third-party COA and LegitScript-certified pharmacy
  • Both telehealth and in-person Utah visits with fast scheduling

Where it loses points

  • Available in Utah only — a St George clinic offering telehealth within the state, not a national service
  • The per-vial price is fixed, so the monthly cost rises steeply with the dose: the provider's own table runs about $20/mo at 0.25 mg, $80/mo at 1.0 mg and about $199/mo at 2.5 mg
  • Medication is bought per vial up front rather than on a subscription, so there is no monthly rate to compare directly against a subscription program
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard